AXA Framlington Biotech Fund Z INCRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/04/2024 |
|
Annual Returns (GBP) | 30/04/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/04 | |
Price Return | 9.64 | -6.41 | 19.37 | 32.70 | 3.40 | 3.76 | 1.84 | -1.70 |
+/- Category | -0.65 | 1.55 | -0.82 | 6.74 | 12.43 | 11.60 | 3.12 | 2.11 |
+/- Category Index | -5.55 | -4.56 | 2.66 | -0.23 | 3.10 | 1.30 | -5.49 | -8.13 |
% Rank in Category | 62 | 50 | 58 | 19 | 7 | 23 | 29 | 37 |
Trailing Returns (GBP) | 09/05/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -0.28 | -1.20 | -0.25 |
1 Week | 1.99 | 0.40 | 0.55 |
1 Month | 1.24 | -1.89 | -1.60 |
3 Months | -0.28 | -3.35 | -4.43 |
6 Months | 12.80 | 16.35 | -2.99 |
YTD | 1.64 | 7.59 | -7.51 |
1 Year | 4.90 | 16.01 | -10.81 |
3 Years Annualised | 5.62 | 13.66 | -3.37 |
5 Years Annualised | 9.09 | 3.25 | -3.69 |
10 Years Annualised* | 11.34 | 0.59 | -0.60 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/04/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 4.52 | - | - | - |
2023 | -3.97 | -1.08 | 0.18 | 7.02 |
2022 | -8.72 | -0.07 | 15.91 | -1.86 |
2021 | -6.24 | 8.04 | 5.37 | -3.13 |
2020 | 0.33 | 29.25 | -2.28 | 4.72 |
2019 | 16.14 | 0.00 | -9.01 | 12.96 |
|
Advertisement |